Related Experiment Video

Updated: Jun 17, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.5K

Low CD4+ cell counts linked to mortality after sustained virological response: evaluating interaction with liver

Anaïs Corma-Gómez1,2,3,4, Jésica Martín-Carmona1,2,3,4, Juan A Pineda1,4

  • 1Clinical Virology and STIs Group, Unit of Infectious Diseases and Microbiology, Hospital Universitario de Valme, Seville, Spain.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|January 15, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.6K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

8.9K

Related Experiment Videos

Last Updated: Jun 17, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
05:53

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty

Published on: July 24, 2013

16.5K
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
07:10

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies

Published on: January 7, 2019

15.6K
Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

8.9K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...

Articles linked to this work by shared authors, journal, and citation graph.

Three-Year CD4/CD8 Ratio Recovery After Initiation of Dual Versus Triple Integrase Inhibitor-Based Therapy in Naïve Adults With HIV.

Open forum infectious diseases·2026

Landscape of copy number variants in Spanish people with dementia.

NPJ genomic medicine·2026

Unmet HIV and STI Prevention Needs and Limited Linkage to Care Among Gay, Bisexual, and Other Men Who Have Sex with Men in Southern Spain: A Community-Based Intervention Study.

AIDS patient care and STDs·2026

Trends in Age-Related Health Outcomes in People with HIV in Spain, 2006-2023.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025

Long-term liver stiffness dynamics after sustained virological response in patients with HIV/HCV co-infection and advanced fibrosis.

AIDS (London, England)·2025

FibroScan-AST Score vs Liver Stiffness for the Prediction of Liver Events After HCV Cure.

Open forum infectious diseases·2025

Cefepime versus piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa pneumonia.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Direct Initiation of Long-Acting Cabotegravir Plus Rilpivirine in People with HIV and Suboptimal Virologic Suppression: A Randomized Trial.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Retrospective Cohort Study Assessing Remdesivir Effectiveness in Hospitalized COVID-19 Patients With Renal or Hepatic Comorbidities.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Financial Impact of a Long-Acting Injectable Cabotegravir/Rilpivirine Program: A Real-World Experience.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Performance and Projected Impact of Synovial Fluid Polymerase Chain Reaction Testing for Patients Evaluated for Septic Arthritis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Should valve leaflet thickening be considered a characteristic lesion of infective endocarditis?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Listerial rhombencephalitis diagnosed by repeat blood culture despite negative CSF PCR: a case report.

ASM case reports·2026

Occurrence and relevance of Gardnerella vaginalis in urine cultures of kidney transplant recipients- a retrospective cohort analysis.

BMC microbiology·2026

Analysis of Endogenously Expressed Double-Stranded RNAs in Human Cultured Cells.

Methods in molecular biology (Clifton, N.J.)·2026

Single-Molecule RNA Fluorescence In Situ Hybridization (smRNA-FISH) Labeling and Imaging of mRNA to Determine Subcellular Localization.

Methods in molecular biology (Clifton, N.J.)·2026

Luciferase Reporter Assay for MicroRNA Target Validation.

Methods in molecular biology (Clifton, N.J.)·2026

Molecular characterization of a novel partitivirus harboring an additional third dsRNA segment from Trichoderma harzianum.

Archives of virology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us